Synthetic Biologics, Inc. SYN
1.02 +1.02
Day range unavailable
52-week range unavailable
News
globenewswire.com Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc. – Theriva received a $350,000 upfront payment at closing and is eligible for up to $91 million in regulatory and sales milestones, along with low single-digit royalties on net product sales – –…
newsfilecorp.com SonicStrategy Closes $2.25 Million SYN Token Financing First tranche settled in kind with 7,922,535 SYN tokens; cash tranche remains open Toronto, Ontario--(Newsfile Corp. - October 8, 2026) - SonicStrategy Inc. (CSE: SONI) (OTCQB: SONIF) (the…
newsfilecorp.com SonicStrategy Acquires Additional SYN Tokens and Announces Grant of Stock Options Toronto, Ontario--(Newsfile Corp. - September 24, 2026) - SonicStrategy Inc. (CSE: SONI) (OTCQB: SONIF) (the "Company"), a publicly traded digital asset infrastructure company, announces that it has…
newsfilecorp.com SonicStrategy Acquires 500,000 SYN Tokens, Expanding Treasury Exposure to On-Chain Derivatives Toronto, Ontario--(Newsfile Corp. - September 23, 2026) - SonicStrategy Inc. (CSE: SONI) (OTCQB: SONIF) (the "Company"), a publicly traded digital asset infrastructure company, announces that it has…
globenewswire.com Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) Interim blinded safety and…
seekingalpha.com Sanofi (SYN) CEO Paul Hudson Hosts 43rd Annual J.P. Morgan Healthcare (Transcript) Sanofi (SYN) 43rd Annual J.P. Morgan Healthcare January 14, 2025 12:45 PM ET Company Participants Paul Hudson - Chief Executive Officer Francois-Xavier Roger - Chief Financial Officer Houman…
globenewswire.com Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China
seekingalpha.com Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q2 2022 Results - Earnings Call Transcript Synthetic Biologics, Inc. (NYSE:SYN ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Chris Calabrese - Investor Relations Steven Shallcross - Chief Executive & Chief…
benzinga.com Earnings Scheduled For August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
benzinga.com Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per…
benzinga.com Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.- benzinga.com Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.
- benzinga.com Why Bank Stocks Traded Sharply Higher; Here Are 65 Biggest Movers From Friday Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock…
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 137 stocks made new 52-week lows.
seekingalpha.com Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q1 2022 Results - Earnings Call Transcript Synthetic Biologics, Inc. (NYSE:SYN ) Q1 2022 Earnings Conference Call May 16, 2022 9:00 AM ET Company Participants Dean Schwartz - LifeSci Advisors, IR Steven Shallcross - CEO and CFO Manel Cascallo…
benzinga.com Earnings Scheduled For May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
globenewswire.com Synthetic Biologics to Host Conference Call and Webcast to Discuss First Quarter 2022 Operational Highlights and Financial Results ROCKVILLE, Md., May 09, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of…
pennystocks.com 5 Top Biotech Penny Stocks Under $1 To Watch This Week Top penny stocks to watch under $1 in April if you like Biotech stocks. The post 5 Top Biotech Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and…
seekingalpha.com Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q4 2021 Results - Earnings Call Transcript Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q4 2021 Results - Earnings Call Transcript
globenewswire.com Synthetic Biologics to Host Conference Call and Webcast to Discuss 2021 Year End Operational Highlights and Financial Results ROCKVILLE, Md., March 10, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of…
prnewswire.com Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference ROCKVILLE, Md., Feb. 9, 2022 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high…
seekingalpha.com Synthetic Biologics, Inc.'s (SYN) CEO Steven Shallcross on Q3 2021 Results - Earnings Call Transcript Synthetic Biologics, Inc.'s (SYN) CEO Steven Shallcross on Q3 2021 Results - Earnings Call Transcript- benzinga.com Earnings Scheduled For November 3, 2021 Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
pennystocks.com 5 Top Penny Stocks To Buy For Under $5 On Webull Today Are these penny stocks on your Webull watch list? The post 5 Top Penny Stocks To Buy For Under $5 On Webull Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
prnewswire.com Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021 ROCKVILLE, Md., Oct. 26, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to…
prnewswire.com Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent…
prnewswire.com Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum ROCKVILLE, Md., Sept. 21, 2021 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to…
investorplace.com 7 Biotech Stocks to Buy That Have Millionaire-Maker Potential This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.- benzinga.com Earnings Scheduled For August 5, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
benzinga.com 26 Stocks Moving in Wednesday's Pre-Market Session Gainers Biomerica, Inc. (NASDAQ: BMRA) shares rose 30.8% to $4.46 in pre-market trading. Biomerica recently said its COVID-19 antigen rapid test can be performed with a nasal swab.- benzinga.com Earnings Scheduled For May 5, 2021 Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
benzinga.com Earnings Scheduled For March 4, 2021 Companies Reporting Before The Bell • Toro (NYSE:TTC) is expected to report quarterly earnings at $0.75 per share on revenue of $851.38 million.- benzinga.com 70 Biggest Movers From Yesterday Gainers CPS Technologies Corporation (NASDAQ: CPSH) shares climbed 113.8% to close at $6.84 on Tuesday. The company, last week, was granted EU patent titled 'Scalable modular design of 48-volt li-ion…
- benzinga.com 52 Stocks Moving In Tuesday's Mid-Day Session Gainers Qilian International Holding Group Ltd (NASDAQ: QLI) shares jumped 76.2% to $8.81 after the company priced its IPO at $5 per share.
- benzinga.com 77 Biggest Movers From Yesterday Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday after gaining over 30% on Monday.
- benzinga.com Earnings Scheduled For November 10, 2020 Companies Reporting Before The Bell • Advance Auto Parts (NYSE:AAP) is projected to report quarterly earnings at $2.66 per share on revenue of $2.48 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday
- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com New 52-Week Lows For Monday Morning
- benzinga.com 50 Biggest Movers From Wednesday
- benzinga.com 34 Stocks Moving In Wednesday's Mid-Day Session
benzinga.com 44 Biggest Movers From Yesterday - benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 9th
- benzinga.com 45 Biggest Movers From Yesterday
- benzinga.com 32 Stocks Moving In Thursday's Mid-Day Session
- benzinga.com 56 Biggest Movers From Yesterday
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, September 19th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, September 17th
- benzinga.com Stocks Which Set New 52-Week Low Friday, September 14